Skip to main content
. 2022 Oct 20;8:136. doi: 10.1038/s41531-022-00388-7

Fig. 1. Assessment of the background and specificity of commercial and homemade pS129 antibodies in vitro and in cellular and animal models.

Fig. 1

a The diagram depicts the workflow of our study to assess the background and specificity of commercial and homemade pS129 antibodies using recombinant aSyn monomers and fibrils (WT or carrying specific PTMs such as nitration, phosphorylation and/or truncation), mammalian cell lines overexpressing aSyn, aSyn KO primary neurons, WT neurons treated with aSyn PFFs or WT mice injected with aSyn PFFs. The background and specificity of the selected pS129 antibodies were evaluated by Western blot analyses or ICC or HTS combined with confocal imaging. Panel A was created using BioRender.com. b The diagram depicts aSyn human sequence, the epitopes of each of the pS129 antibodies (whenever available), and the post-translational modifications that can occur concomitantly in the C-terminal region of aSyn. c The diagram depicts truncations that occurs in the different regions of aSyn in human brains and the appendix.